Proponents of resveratrol criticized the ITP study for low bioavailability, suggesting much higher doses are needed, a criticism voiced only after the study's negative results.

“um and nothing happened now the folks who say RIS veratrol Works have criticize that study saying the bioavailability is low and therefore you need much much much more than the 300 PPM uh that was given in that study uh but again that was a concern and a criticism that was only voiced after the study the proponents of R veratrol were involved in that study um and they signed off I mean they're they're on the paper I mean they they this was this was their view so um I I I just have a hard time believing that there is any value in RIS veratrol”